Kaiser Health News, an editorially independent news service, is a scheduled plan of the Kaiser Family members Foundation, a nonpartisan healthcare policy research organization unaffiliated with Kaiser Permanente. today announced that the independent Data Monitoring Committee of the Phase 3 SUCCEED trial has completed the first interim efficacy analysis as specified by the study protocol and has recommended that the randomized, placebo-managed trial of oral ridaforolimus in individuals with metastatic sarcomas continue steadily to full patient enrollment and completion.But authorities in the tiny southern city of Lebrija aren’t acquiring any chances. They organized a doctor’s appointment to ensure the young mother and her baby are doing well. If so, they could have dodged some bullets: very young mothers are known to encounter improved risk for high blood circulation pressure and other health issues, and their babies will be born prematurely. In a statement, city officials said they are investigating when the pregnant child arrived in Spain and why she hadn’t seen a doctor before showing up the other day at a hospital to give birth.